Real Tech Fund develops blood glucose sensor that does not require blood sampling
Invested in "Light Touch Technology Co., Ltd."

Euglena Investment Co., Ltd.

　Euglena Investment Co., Ltd. (Headquarters: Minato-ku, Tokyo, Representative: Akihiko Nagata) is a new investment destination for the R & D-specialized venture capital fund "Real Tech Fund", Light Touch Technology Co., Ltd. (hereinafter, LTT). We would like to inform you that we have invested in.

　LTT is developing a blood glucose level sensor that does not require blood sampling by applying advanced laser technology and optical parametric oscillation * technology. In addition to greatly reducing the pain of diabetic patients who need daily blood sampling to measure blood glucose levels, it is possible to measure blood glucose levels in real time for a long time, and by obtaining information such as sudden fluctuations in blood glucose levels due to meals, etc. , It is possible to treat individualized diabetes according to each patient.
* Optical parametric oscillation: A technology that uses nonlinear optical crystals to increase the intensity of light of a specific wavelength.
　The Real Tech Fund will underwrite the shares issued by LTT through a third-party allotment, and the 2017 “Research” by the National Research and Development Corporation New Energy and Industrial Technology Development Organization (NEDO), which was adopted by LTT. Development-type venture support business / Commercialization support for R & D-type ventures in the seed period ”As a certified VC of the subsidy business, we will support the company's R & D, sales and marketing activities.
　The details are as follows.

About investment of Light Touch Technology Co., Ltd.

■ About the outline and support contents of Light Touch Technology Co., Ltd.
　Date of establishment: July 10, 2017
　location　: 2-8 Motomachibashi, Chuo-ku, Osaka-shi, Osaka Inside the Osaka Chamber of Commerce and Industry
　Representative　: Representative Director Koichi Yamakawa
　Capital　: 6.15,000 yen (excluding capital reserve)
　Business: Development, manufacture and sale of non-invasive blood glucose sensor
　HP　　: Https://www.light-tt.co.jp
　Support content: Promotion of cooperation with fund-funded companies, support for research and development, sales and marketing activities
　Investment period: October 2017

■ About Realtech Fund (HP: http://www.realtech.fund)
　Our 100% subsidiary of Euglena Investment, SMBC Nikko Securities, Ribanesu "Limited Liability Company was founded three companies Euglena in venture capital funds that SMBC Nikko Ribanesu capital" to management and operation, the investment development of the real tech venture as the main purpose is. With a total of 30 participating companies and a fund size of 9.4 billion yen (as of November 2017), it is Japan's largest fund specializing in real tech. We are investing in and nurturing real-tech ventures together with the operating companies that are our investors.

that's all　　　　　　　　　　

 -Contact for inquiries from the press-
Euglena Co., Ltd. Corporate Communication Division